IP Verse

Generics (uk) Ltd opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Generics (uk) Ltd

Patent Number:
EP3110449
Title:
Medical Use Of A Dpp-4 Inhibitor
Applicant:
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Opposition Date:
Mar 28, 2024
Patent Number:
EP3613421
Title:
Dry Powder Inhaler And Methods Of Use
Applicant:
OTITOPIC INC.
Opposition Date:
Feb 2, 2024
Patent Number:
EP3811943
Title:
Compound For Use In The Treatment Of Ocular Disorders
Applicant:
AERIE PHARMACEUTICALS, INC.
Opposition Date:
Nov 22, 2023
Patent Number:
EP3285776
Title:
Methods Of Treating Bacterial Infections
Applicant:
MELINTA THERAPEUTICS, INC.
Opposition Date:
Sep 21, 2023
Patent Number:
EP3067043
Title:
Pharmaceutical Compositions Based On Superstructures Of Angiotensin Receptor Antagonist/Blocker (Arb) And Neutral Endopeptidase (Nep) Inhibitor
Applicant:
NOVARTIS AG
Opposition Date:
Aug 30, 2023
Patent Number:
EP3300729
Title:
Therapeutic Compositions Containing Macitentan
Applicant:
ACTELION PHARMACEUTICALS LTD
Opposition Date:
Jul 9, 2020
Patent Number:
EP3038654
Title:
New Use
Applicant:
NOVARTIS AG
Opposition Date:
Jul 6, 2020
Patent Number:
EP2694050
Title:
Tapentadol For Treating Pain Associated With Trigeminal Neuralgia
Applicant:
GRÜNENTHAL GMBH
Opposition Date:
Jul 2, 2020
Patent Number:
EP3248600
Title:
Combinations And Modes Of Administration Of Therapeutic Agents And Combination Therapy
Applicant:
ABRAXIS BIOSCIENCE, LLC
Opposition Date:
Apr 24, 2020
Patent Number:
EP2687213
Title:
Solid Forms Comprising (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione, Compositions Thereof, And Uses Thereof
Applicant:
AMGEN (EUROPE) GMBH
Opposition Date:
Mar 19, 2020

Competitors of Generics (uk) Ltd

NOVARTIS AG

CELGENE CORPORATION

ALKERMES PHARMA IRELAND LIMITED

Want to track Generics (uk) Ltd?

Feel free to send us a message here and we will get back to you